References
1. Levine SM, Hellmann DB. Giant cell arteritis. Curr Opin Rheumatol 2002;14:3–10.
2. Gonzalez-Gay MA, Garcia-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am2001;27:729–749.
3. Huston KA, Hunder GG, Lie JT, et al. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 1978;88:162–167.
4. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, et al. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore) 2005;84:269–276.
5. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 2000;79:283–292.
6. Weyand CM, Goronzy JJ. Arterial wall injury in giant cell arteritis. Arthritis Rheum 1999;42:844–853.
7. Healey LA, Wilske KR. Presentation of occult giant cell arteritis. Arthritis Rheum 1980;23:641–643.
8. Calamia KT, Hunder GG. Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. Arthritis Rheum 1981;24:1414–1418.
9. Desmet GD, Knockaert DC, Bobbaers HJ. Temporal arteritis: the silent presentation and delay in diagnosis. J Intern Med 1990;227:237–240.
10. Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, et al. Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population. Arthritis Rheum 2004;51:652–655.
11. Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, et al. Giant cell arteritis without clinically evident vascular involvement in a defined population. Arthritis Rheum 2004;51:274–277.
12. Chuang TY, Hunder GG, Ilstrup DM, et al. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982;97:672–680.
13. Healey LA. The spectrum of polymyalgia rheumatica. Clin Geriatr Med 1988;4:323–331.
14. Cantini F, Niccoli L, Storri L, et al. Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum 2004;33:294–301.
15. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol 1998;25:1750–1755.
16. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M, et al. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a ten year-study. J Rheumatol 1999;26:1326–1332.
17. Gonzalez-Gay MA. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum 2004;33:289–293.
18. Gonzalez-Gay MA, Garcia-Porrua C, Rivas MJ, et al. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. Ann Rheum Dis 2001;60:367–371.
19. Kathula SK, Mantil J, Drehmer T, et al. Giant cell arteritis mimicking multiple myeloma, diagnosed by PET scan. South Med J 2006;99:1280–1281.
20. Gonzalez-Gay MA. The diagnosis and management of patients with giant cell arteritis. J Rheumatol2005;32:1186–1188.
21. Schmidt WA, Blockmans D. Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis. Curr Opin Rheumatol 2005;17:9–15.
22. Gonzalez-Gay MA, Garcia-Porrua C, Miranda-Filloy JA. Giant cell arteritis: diagnosis and therapeutic management. Curr Rheumatol Rep 2006; 8:299–302.